Overview
Join us for BIO BREAK, a monthly happy hour for professionals in the Dallas Life Sciences community. Hosted by McDermott and BioNTX, this premier event provides an opportunity for networking, collaboration and celebrating the remarkable strides made in the field.
This month, we are excited to welcome Caidya, a multi-therapeutic clinical research organization, as sponsor of the May BIO BREAK.
This series was created in light of our region’s recent ARPA-H win. Dallas was named “one of three U.S. hubs for a $2.5 billion federal biotech research agency after months of targeted campaigning by Texas cities, universities and science advocates, cementing North Texas’ place among the nation’s major Life Sciences hubs.”
We hope to see you there!
RSVP today to attend.
For questions, please contact Maddie Goodell.
About Caidya:
Caidya is a multi-therapeutic clinical research organization (CRO) serving innovators worldwide. Focused on delivery excellence and an elevated customer experience, Caidya offers a wide range of clinical services and vast therapeutic expertise, supporting its partners from pre-IND strategy, through clinical development to submission and post-marketing surveillance.
Caidya leverages industry-leading and proprietary clinical technology to ensure trial transparency and data-driven decision-making. Formed in 2021 following the combination of leading CROs, dMed and Clinipace, Caidya has nearly 1,800 employees in more than 30 countries throughout the world.
